Abstract:A single compound able to inhibit both Topo Ⅰ and Ⅱ may present the advantage of improving anti-proliferative activity,with reduced toxic side effects,with respect to the combination of two inhibitors.We designed and synthesized 28 compounds of indeno[1,2-b]indole derivatives as a new class of Topo Ⅰ and Ⅱ inhibitor and successfully identified compound 2-3j,which showed the most potent cell growth inhibition with IC50=0.74 μM against HCT-116 cell line.Compound 2-3j was also evaluated as a potent topoisomerase Ⅰ and Ⅱ inhibitor and can induce apoptosis in human colon cancer cells.2-3j showed potency against a small panel of drug sensitive and multidrug resistant (MDR) cell lines,and it reversed the MDR of K562/A02,MCF-7/Adr,and KB/Vcr cells at 0.5 μM,with reversal fold values of 3.2,10.1,and 5.8,respectively.2-3j might inhibit the function of ABCG2 to increase intracellular drug accumulation and enhance the sensitivity of conventional chemotherapeutic agents for MDR cells.2-3j could be a promising lead for the development of a new class of antitumor drug acting as inhibitors of Topo Ⅰ & Ⅱ and ABCG2.

Synthesis and biological evaluation of indeno[1, 2-b]indole derivatives as dual topoisomerase Ⅰ & Ⅱ inhibitors: novel multidrug resistant reversal anticancer agents